Incannex Healthcare Inc. announced positive findings from its IHL-42X study for treating obstructive sleep apnea (OSA), paving the way for a future FDA 505(b)(2) new drug application. The company ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback